How to buy Tricida stock

Tricida is a biotechnology & medical research business based in the US. Tricida stocks (TCDA.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.013 – the same closing value as a week prior. Tricida employs 57 staff and has a market cap (total outstanding stock value) of $6.3 million.

Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
Open an account. Provide your personal information and sign up.
Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
Search for the stock name – TCDA. Search for the stock by name or ticker symbol.
Buy the stock. Place your order. It's that simple.

National Bank Direct Brokerage

Go to site

Commission-free trading
Several account types available
Access to array of research tools

CIBC Investor's Edge

Go to site

Easy to use platform
Low fees
Student and young investor discounts

Finder Award

Interactive Brokers

Go to site

Access to international stock exchanges
Low margin rates
Powerful research tools

Our selection of top picks is based on the same criteria as our annual Stock Trading Platform Awards. This is updated yearly to reflect changes in the market.

"Best for" picks are those we've evaluated to be best for specific product features or categories – you can read our full methodology here. If we show a "Promoted" pick, it's been chosen from among our commercial partners and is based on factors that include special features or offers, and the commission we receive.

This isn't an exhaustive list of all the trading platforms out there. What's best for you depends on your own investing strategy, budget and financial goals.

Tricida stock price (NASDAQ:TCDA)

Use our graph to track the performance of TCDA stocks over time.

Tricida shares at a glance

Key figures

Information last updated 2023-03-28.

Latest market close	$0.01
52-week range	$0.01 - $13.85
50-day moving average	$0.16
200-day moving average	$6.64
Wall St. target price	$20.00
PE ratio	N/A
Dividend yield	$0 (0%)
Earnings per share (TTM)	$-2.88

Buy Tricida stocks from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Note: The dollar amounts in the table below are in Canadian dollars.

1 - 5 of 5

Name	Finder Rating	Available Asset Types	Stock Trading Fee	Account Fee	Signup Offer	Table description
CIBC Investor's Edge CIBC Investor's Edge	Finder Rating: ★★★★★ 3.8 / 5	Stocks, Bonds, Options, Mutual Funds, ETFs	$4.95–$6.95	$0 if conditions met, or $100	N/A	An easy-to-use platform with access to a variety of tools to help you trade with confidence.	Go to site View details	Compare	loading Fetching your data...
Interactive Brokers Interactive Brokers Finder Award	Finder Rating: ★★★★★ 4.3 / 5	Stocks, Bonds, Options, ETFs, Currencies, Futures	min $1.00, max 0.5%	$0	N/A	Winner for Best Overall Broker in the Finder Stock Trading Platform Awards.	Go to site View details	Compare	loading Fetching your data...
National Bank Direct Brokerage National Bank Direct Brokerage	Finder Rating: ★★★★★ 4.2 / 5	Stocks, Bonds, Options, Mutual Funds, GICs	$0	$0 if conditions met, or $100	Get $0 commission on all transactions with promo code: finder		Go to site View details	Compare	loading Fetching your data...
Questrade Questrade	Finder Rating: ★★★★★ 4.3 / 5	Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals	$4.95 - $9.95	$0	Get $50 in free trades when you fund your account with a minimum of $1,000.	Opt for self-directed investing and save on fees or get a pre-built portfolio to take out some of the guesswork.	Go to site View details	Compare	loading Fetching your data...
Qtrade Direct Investing Qtrade Direct Investing	Finder Rating: ★★★★★ 3.7 / 5	Stocks, Bonds, Options, Mutual Funds, ETFs, GICs	$6.95 - $8.75	$0 if conditions met, otherwise $25/quarter	Get up to $150 sign-up bonus. Use promo code BONUS150. Conditions apply. Ends June 30, 2023.	Low trading commissions and an easy-to-use platform with access to powerful tools and a wide selection of investment options.	Go to site View details	Compare	loading Fetching your data...

Is it a good time to buy Tricida stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Tricida price performance over time

Historical closes compared with the close of $0.0141 from 2023-03-27

1 week (2023-05-24)	N/A
1 month (2023-04-30)	N/A
3 months (2023-03-01)	12.80%
6 months (2022-12-02)	-94.27%

1 year (2022-06-01)	-99.83%
2 years (2021-06-04)	-99.70%
3 years (2020-06-04)	25.98
5 years (2018-05-31)	N/A

[/expander_content] [/expander]

Tricida financials

Gross profit TTM	$0
Return on assets TTM	-60.11%
Return on equity TTM	-323.71%
Profit margin	0%
Book value	$-2.44
Market capitalisation	$6.3 million

TTM: trailing 12 months

Tricida share dividends

We're not expecting Tricida to pay a dividend over the next 12 months.

Have Tricida's shares ever split?

Tricida's shares were split on a 1:3 basis on 15 June 2018. So if you had owned 3 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Tricida shares – just the quantity. However, indirectly, the new 200% higher share price could have impacted the market appetite for Tricida shares which in turn could have impacted Tricida's share price.

Tricida share price volatility

Over the last 12 months, Tricida's shares have ranged in value from as little as $0.012 up to $13.85. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Tricida's is 0.2126. This would suggest that Tricida's shares are less volatile than average (for this exchange).

Tricida overview

Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company was incorporated in 2013 and is headquartered in South San Francisco, California. On January 11, 2023, Tricida, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U. S.

Stocks similar to Tricida

Brickell Biotech Inc

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

Ask an Expert

Click here to cancel reply.

You must be logged in to post a comment.

How to buy Tricida stock in Canada

Learn how to buy Tricida stock in 5 easy steps.